The Newsroom
Find out the latest about Calidi. Announcements, press coverage, publications, and company info—it’s all here.
Press Release
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
Calidi Biotherapeutics announced a new patent for its SuperNova technology, advancing its CLD-201 program into the clinic. The patent covers a unique cancer treatment combining stem cells and a smallpox vaccine. This strengthens Calidi’s position in developing innovative therapies for advanced solid tumors.
![A close up of a cell in the air.](https://cdn.prod.website-files.com/64bdd6d425cea7848e868875/64cc3fd22bbb002ba4a582c8_CleanShot%202023-08-03%20at%2018.00.37%402x.webp)
Press Release
event
SuperNova (SNV)
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
July 18, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
July 16, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi to Effect Reverse Stock Split
July 5, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors
June 27, 2024
Discover More
Discover More
Discover More
Press Release
event
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13
June 11, 2024
Discover More
Discover More
Discover More
Press Release
event
RTNova
NeuroNova
Supernova
RTNova
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors
June 10, 2024
Discover More
Discover More
Discover More
Press Release
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
June 3, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
May 31, 2024
Discover More
Press Release
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results
May 14, 2024
Discover More
Press Release
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
May 1, 2024
Discover More
Press Release
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
April 19, 2024
Discover More
Press Release
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering
April 16, 2024
Discover More
Publication
event
RTNova
RTNova
NeuroNova
Supernova
Transforming Tumor Immune Microenvironments with a Novel Systemic Enveloped Oncolytic Virotherapy Targeting All Tumor Sites
June 1, 2024
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
Non-Clinical Evidence Supporting the Upcoming CLD-201 Clinical Trial: Cell-Based Oncolytic Virotherapy for Multiple Solid Tumors
June 1, 2024
Discover More
Discover More
Publication
event
NeuroNova (NNV)
NeuroNova (NNV)
NeuroNova
Supernova
Phase 1 Study of Multiple Intracerebral Doses of a Neural Stem Cell-based Oncolytic Virotherapy for Treatment of Recurrent High-grade Gliomas
June 1, 2024
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova & SuperNova
NeuroNova
Supernova
Stem Cell Platforms for Enhanced Oncolytic Virotherapy
April 16, 2024
Discover More
Discover More
Publication
event
NeuroNova & SuperNova
NeuroNova & SuperNova
NeuroNova
Supernova
Deciphering Anticancer Mechanisms of Oncolytic Virus-loaded Stem Cells
April 9, 2024
Discover More
Discover More
Publication
event
SuperNova (SNV)
SuperNova (SNV)
NeuroNova
Supernova
Annual Meeting – SITC 2023 – Nov 1st to 5th 2023 in San Diego, CA, USA.
November 3, 2023
Discover More
Discover More
Media
Scientific Advisory Board Member Interview - Ashok Srivastava, MD/PH.D.
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - W.K. Alfred Yung, MD
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Bernard Fox, PhD,
February 3, 2024
Discover More
Media
Scientific Advisory Board Member Interview - Santosh Kesari, MD/PH.D.
February 3, 2024
Discover More
Media
Big Biz TV - Allan Camaisa
December 4, 2023
Discover More
Media
Big Biz TV - Stephen Thesing
December 4, 2023
Discover More
In The News
Calidi Biotherapeutics: A Promising Player in the Cancer Treatment Market
October 9, 2023
Discover More
Discover More
In The News
Analyst Bullish On Calidi Biotherapeutics, Newly Listed Cancer Treatment Player
October 9, 2023
Discover More
Discover More